199 related articles for article (PubMed ID: 38194773)
1. Peptide-drug conjugates: A new paradigm for targeted cancer therapy.
Wang M; Liu J; Xia M; Yin L; Zhang L; Liu X; Cheng Y
Eur J Med Chem; 2024 Feb; 265():116119. PubMed ID: 38194773
[TBL] [Abstract][Full Text] [Related]
2. Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
Fu C; Yu L; Miao Y; Liu X; Yu Z; Wei M
Acta Pharm Sin B; 2023 Feb; 13(2):498-516. PubMed ID: 36873165
[TBL] [Abstract][Full Text] [Related]
3. Progress and Future Directions with Peptide-Drug Conjugates for Targeted Cancer Therapy.
Lindberg J; Nilvebrant J; Nygren PÅ; Lehmann F
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641586
[TBL] [Abstract][Full Text] [Related]
4. Gold nanoparticles stabilize peptide-drug-conjugates for sustained targeted drug delivery to cancer cells.
Kalimuthu K; Lubin BC; Bazylevich A; Gellerman G; Shpilberg O; Luboshits G; Firer MA
J Nanobiotechnology; 2018 Mar; 16(1):34. PubMed ID: 29602308
[TBL] [Abstract][Full Text] [Related]
5. Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy.
Kim H; Hwang D; Choi M; Lee S; Kang S; Lee Y; Kim S; Chung J; Jon S
Mol Pharm; 2019 Jan; 16(1):165-172. PubMed ID: 30521347
[TBL] [Abstract][Full Text] [Related]
6. Multivalent protein-drug conjugates - An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells.
Porębska N; Ciura K; Chorążewska A; Zakrzewska M; Otlewski J; Opaliński Ł
Biotechnol Adv; 2023 Oct; 67():108213. PubMed ID: 37453463
[TBL] [Abstract][Full Text] [Related]
7. Peptide Drug Conjugates and Their Role in Cancer Therapy.
Heh E; Allen J; Ramirez F; Lovasz D; Fernandez L; Hogg T; Riva H; Holland N; Chacon J
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614268
[TBL] [Abstract][Full Text] [Related]
8. Peptide-Drug Conjugate: A Novel Drug Design Approach.
Ma L; Wang C; He Z; Cheng B; Zheng L; Huang K
Curr Med Chem; 2017; 24(31):3373-3396. PubMed ID: 28393694
[TBL] [Abstract][Full Text] [Related]
9. Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs).
Cooper BM; Iegre J; O' Donovan DH; Ölwegård Halvarsson M; Spring DR
Chem Soc Rev; 2021 Feb; 50(3):1480-1494. PubMed ID: 33346298
[TBL] [Abstract][Full Text] [Related]
10. Drug conjugate-based anticancer therapy - Current status and perspectives.
Yang Y; Wang S; Ma P; Jiang Y; Cheng K; Yu Y; Jiang N; Miao H; Tang Q; Liu F; Zha Y; Li N
Cancer Lett; 2023 Jan; 552():215969. PubMed ID: 36279982
[TBL] [Abstract][Full Text] [Related]
11. Peptide-Drug Conjugates with Different Linkers for Cancer Therapy.
Alas M; Saghaeidehkordi A; Kaur K
J Med Chem; 2021 Jan; 64(1):216-232. PubMed ID: 33382619
[TBL] [Abstract][Full Text] [Related]
12. Oxime-Linked Peptide-Daunomycin Conjugates as Good Tools for Selection of Suitable Homing Devices in Targeted Tumor Therapy: An Overview.
Mező G; Gomena J; Ranđelović I; Dókus EL; Kiss K; Pethő L; Schuster S; Vári B; Vári-Mező D; Lajkó E; Polgár L; Kőhidai L; Tóvári J; Szabó I
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339141
[TBL] [Abstract][Full Text] [Related]
13. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment.
Paulus J; Sewald N
J Pept Sci; 2024 Jul; 30(7):e3561. PubMed ID: 38382900
[TBL] [Abstract][Full Text] [Related]
14. Peptide cargo administration: current state and applications.
Rohira H; Arora A; Kaur P; Chugh A
Appl Microbiol Biotechnol; 2023 May; 107(10):3153-3181. PubMed ID: 37052636
[TBL] [Abstract][Full Text] [Related]
15. Learn from antibody-drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy.
Wu M; Huang W; Yang N; Liu Y
Exp Hematol Oncol; 2022 Nov; 11(1):93. PubMed ID: 36348391
[TBL] [Abstract][Full Text] [Related]
16. A Review on Exploring the Opportunities of Polymer Drug Conjugated Systems for Targeted Cancer Treatment.
Gupta C; Naik I; Menon M; Ambre P; Coutinho E
Curr Drug Deliv; 2022; 20(1):8-30. PubMed ID: 35400344
[TBL] [Abstract][Full Text] [Related]
17. Advances in targeted therapy for pancreatic cancer.
Xing L; Lv L; Ren J; Yu H; Zhao X; Kong X; Xiang H; Tao X; Dong D
Biomed Pharmacother; 2023 Dec; 168():115717. PubMed ID: 37862965
[TBL] [Abstract][Full Text] [Related]
18. Targeted drug delivery for cancer therapy: the other side of antibodies.
Firer MA; Gellerman G
J Hematol Oncol; 2012 Nov; 5():70. PubMed ID: 23140144
[TBL] [Abstract][Full Text] [Related]
19. Construction of Peptide-Drug Conjugates for Selective Targeting of Malignant Tumor Cells.
Vrettos EI; Tzakos AG
Methods Mol Biol; 2021; 2207():327-338. PubMed ID: 33113145
[TBL] [Abstract][Full Text] [Related]
20. Peptide-drug conjugates as effective prodrug strategies for targeted delivery.
Wang Y; Cheetham AG; Angacian G; Su H; Xie L; Cui H
Adv Drug Deliv Rev; 2017 Feb; 110-111():112-126. PubMed ID: 27370248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
